{"id":"W2038900287","doi":"10.1097/qai.0b013e3181cae4a1","title":"Prospective, Randomized, Open Label Trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ Treatment-Naive Subjects With CD4+<200 cell/mm3 in Mexico","year":2010,"lang":"en","type":"article","venue":"JAIDS Journal of Acquired Immune Deficiency Syndromes","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Institute on Drug Abuse","keywords":"Lopinavir/ritonavir; Efavirenz; Lopinavir; Medicine; Ritonavir; Lamivudine; Internal medicine; Confidence interval; Viral load; Gastroenterology; Randomized controlled trial; Clinical endpoint; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002264627,0.000603779,0.003006415,0.0014016,0.0001160548,0.0000882963,0.000656157,0.0002470474,0.0001089919],"category_scores_gemma":[0.0004282302,0.0003963306,0.0003794097,0.001624183,0.0004618985,0.0006791697,0.0001445532,0.000391015,0.00004173436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004684942,"about_ca_system_score_gemma":0.001230587,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002156348,"about_ca_topic_score_gemma":0.0001187338,"domain_scores_codex":[0.995342,0.0003626842,0.002161948,0.0005282012,0.0009045146,0.0007006646],"domain_scores_gemma":[0.9970212,0.0006166844,0.001226953,0.0005909808,0.0003440742,0.0002001166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7748329,0.01581116,0.1791529,0.0002097673,0.0009541652,0.00325322,0.006877502,0.00003443002,0.01506852,0.0006262644,0.0001856699,0.002993449],"study_design_scores_gemma":[0.9205582,0.007974438,0.04304625,0.001153219,0.0006259507,0.001117437,0.001011496,0.00007036821,0.02331885,0.0003996855,0.0002088649,0.0005152617],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902723,0.001565787,0.00002387313,0.001041121,0.0005831572,0.0035014,0.00001613614,0.00002670301,0.002969552],"genre_scores_gemma":[0.9895927,0.0007880378,0.00473365,0.00002193855,0.00005591058,0.0002068578,0.00002698796,0.00007510802,0.004498763],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1457253,"threshold_uncertainty_score":0.9998488,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01787101026118139,"score_gpt":0.2887138184398692,"score_spread":0.2708428081786878,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}